Activation of KCNQ4 as a Therapeutic Strategy to Treat Hearing Loss
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Activation of KCNQ4 as a Therapeutic Strategy to Treat Hearing Loss
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 5, Pages 2510
Publisher
MDPI AG
Online
2021-03-03
DOI
10.3390/ijms22052510
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Guanylyl Cyclase A/cGMP Signaling Slows Hidden, Age- and Acoustic Trauma-Induced Hearing Loss
- (2020) Philine Marchetta et al. Frontiers in Aging Neuroscience
- Inner Ear Gene Therapies Take Off: Current Promises and Future Challenges
- (2020) Sedigheh Delmaghani et al. Journal of Clinical Medicine
- Structural Basis for the Modulation of Human KCNQ4 by Small-Molecule Drugs
- (2020) Tian Li et al. MOLECULAR CELL
- Age-related hearing loss pertaining to potassium ion channels in the cochlea and auditory pathway
- (2020) Barbara Peixoto Pinheiro et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis
- (2020) Brian J. Wainger et al. JAMA Neurology
- Synthesis and Optimization of Kv7 (KCNQ) Potassium Channel Agonists: The Role of Fluorines in Potency and Selectivity
- (2019) Ruiting Liu et al. ACS Medicinal Chemistry Letters
- Inner Hair Cell and Neuron Degeneration Contribute to Hearing Loss in a DFNA2-Like Mouse Model
- (2019) Camila Carignano et al. NEUROSCIENCE
- Rare KCNQ4 variants found in public databases underlie impaired channel activity that may contribute to hearing impairment
- (2019) Jinsei Jung et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- World Health Organization and Its Initiative for Ear and Hearing Care
- (2018) Shelly Chadha et al. OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA
- Genetic variation in KCNQ4 gene is associated with susceptibility to noise-induced hearing loss in a Chinese population
- (2018) Haoran Guo et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- TMC1 Forms the Pore of Mechanosensory Transduction Channels in Vertebrate Inner Ear Hair Cells
- (2018) Bifeng Pan et al. NEURON
- A recurrent mutation in KCNQ4 in Korean families with nonsyndromic hearing loss and rescue of the channel activity by KCNQ activators
- (2018) Dong Hoon Shin et al. HUMAN MUTATION
- Discovery of Novel Retigabine Derivatives as Potent KCNQ4 and KCNQ5 Channel Agonists with Improved Specificity
- (2018) Lei Wang et al. ACS Medicinal Chemistry Letters
- Whole-exome sequencing identifies two novel mutations in KCNQ4 in individuals with nonsyndromic hearing loss
- (2018) Jinsei Jung et al. Scientific Reports
- Hearing Loss in Adults
- (2017) Lisa L. Cunningham et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selective activation of vascular Kv7.4/Kv7.5 K+channels by fasudil contributes to its vasorelaxant effect
- (2016) Xuan Zhang et al. BRITISH JOURNAL OF PHARMACOLOGY
- KCNQ channel openers reverse depressive symptoms via an active resilience mechanism
- (2016) Allyson K. Friedman et al. Nature Communications
- Potassium ion channel openers, Maxipost and Retigabine, protect against peripheral salicylate ototoxicity in rats
- (2015) Adam M. Sheppard et al. HEARING RESEARCH
- Vasorelaxant effects of novel Kv7.4 channel enhancers ML213 and NS15370
- (2014) T A Jepps et al. BRITISH JOURNAL OF PHARMACOLOGY
- Activation of Peripheral KCNQ Channels Attenuates Inflammatory Pain
- (2014) Hiroki Hayashi et al. Molecular Pain
- From Pan-Reactive KV7 Channel Opener to Subtype Selective Opener/Inhibitor by Addition of a Methyl Group
- (2014) Sigrid Marie Blom et al. PLoS One
- Cardiovascular responses to retigabine in conscious rats - under normotensive and hypertensive conditions
- (2013) L V Fretwell et al. BRITISH JOURNAL OF PHARMACOLOGY
- Characterization of a novel high-potency positive modulator of Kv7 channels
- (2013) William Dalby-Brown et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Impaired surface expression and conductance of the KCNQ4 channel lead to sensorineural hearing loss
- (2013) Yanhong Gao et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Comprehensive Genetic Screening of KCNQ4 in a Large Autosomal Dominant Nonsyndromic Hearing Loss Cohort: Genotype-Phenotype Correlations and a Founder Mutation
- (2013) Takehiko Naito et al. PLoS One
- Kv7.1 ion channels require a lipid to couple voltage sensing to pore opening
- (2013) M. A. Zaydman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy
- (2012) Martin J. Gunthorpe et al. EPILEPSIA
- The urinary safety profile and secondary renal effects of retigabine (ezogabine): A first-in-class antiepileptic drug that targets KCNQ (Kv7) potassium channels
- (2012) Neil Brickel et al. EPILEPSIA
- Contribution of genetic factors to noise-induced hearing loss: A human studies review
- (2012) Mariola Sliwinska-Kowalska et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Discovery, Synthesis, and Structure–Activity Relationship of a Series of N-Aryl-bicyclo[2.2.1]heptane-2-carboxamides: Characterization of ML213 as a Novel KCNQ2 and KCNQ4 Potassium Channel Opener
- (2011) Haibo Yu et al. ACS Chemical Neuroscience
- Restoration of ion channel function in deafness-causing KCNQ4 mutants by synthetic channel openers
- (2011) Michael G Leitner et al. BRITISH JOURNAL OF PHARMACOLOGY
- Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy
- (2011) J. A. French et al. NEUROLOGY
- Effects of the potassium ion channel modulators BMS-204352 Maxipost and its R-enantiomer on salicylate-induced tinnitus in rats
- (2011) Edward Lobarinas et al. PHYSIOLOGY & BEHAVIOR
- Hearing loss: a common disorder caused by many rare alleles
- (2010) Dorith Raviv et al. Annals of the New York Academy of Sciences
- KV7 channelopathies
- (2010) Snezana Maljevic et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Analysis of Gene Polymorphisms Associated with K+Ion Circulation in the Inner Ear of Patients Susceptible and Resistant to Noise-induced Hearing Loss
- (2009) Malgorzata Pawelczyk et al. ANNALS OF HUMAN GENETICS
- Effects of neuronal Kv7 potassium channel activators on hyperactivity in a rodent model of mania
- (2009) John P. Redrobe et al. BEHAVIOURAL BRAIN RESEARCH
- Genetic Studies on Noise-Induced Hearing Loss: A Review
- (2009) Annelies Konings et al. EAR AND HEARING
- Voltage-gated potassium channels as therapeutic targets
- (2009) Heike Wulff et al. NATURE REVIEWS DRUG DISCOVERY
- Cochlear amplification, outer hair cells and prestin
- (2008) Peter Dallos CURRENT OPINION IN NEUROBIOLOGY
- Combinatorial augmentation of voltage-gated KCNQ potassium channels by chemical openers
- (2008) Q. Xiong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activation of Kv7 (KCNQ) voltage-gated potassium channels by synthetic compounds
- (2008) Q XIONG et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now